The Ever-Increasing Impact of Gene Therapy in Rare Oncology Trials, Upcoming Webinar Hosted by Xtalks
As oncology trials become more complex, scientists are finding that the oncogenic drivers of disease are crafting more discrete patient populations and are therefore turning what was once a very generalized disease state into a rare indication. Now, we are not only working with oncogenic drivers, but also the very[…]
Read more